Related Experiment Video
Updated: Nov 7, 2025
06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
320
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement
Laurent Faroux1, Thibault Lhermusier2, Flavien Vincent3
1Quebec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.
Journal of the American College of Cardiology
|April 30, 2021
Summary
Patients experiencing ST-segment elevation myocardial infarction (STEMI) after transcatheter aortic valve replacement (TAVR) face high mortality risks. This is linked to longer procedure times and higher percutaneous coronary intervention (PCI) failure rates in this population.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Background:
- Patients undergoing transcatheter aortic valve replacement (TAVR) are at risk for acute coronary syndrome.
- ST-segment elevation myocardial infarction (STEMI) following TAVR represents a particularly high-risk subgroup.
Purpose of the Study:
- To investigate the clinical characteristics of STEMI post-TAVR.
- To analyze the management strategies and outcomes for STEMI after TAVR.
- To compare STEMI outcomes in TAVR patients with a general STEMI population.
Main Methods:
- Multicenter study of 118 patients with STEMI after TAVR.
- Comparison of primary percutaneous coronary intervention (PCI) in TAVR patients versus 439 non-TAVR STEMI patients.
- Analysis of procedural data, including door-to-balloon times and PCI failure rates.
Main Results:
- STEMI patients post-TAVR had longer door-to-balloon times (40 min vs. 30 min) and higher PCI failure rates (16.5% vs. 3.9%).
- Coronary ostia cannulation failure was a specific challenge in TAVR patients.
- In-hospital and late mortality rates were high (25.4% and 42.4% respectively).
- Factors predicting increased risk included low estimated glomerular filtration rate, Killip class ≥2, and PCI failure.
Conclusions:
- STEMI after TAVR is associated with significantly high mortality.
- Challenges in PCI, including coronary access issues, contribute to poorer outcomes.
- Timely intervention and management of comorbidities are crucial for improving survival.
Keywords:
ST-segment elevation myocardial infarctionacute coronary syndromemortalitypercutaneous coronary interventiontranscatheter aortic valve replacementMore Related Videos
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
239
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
239
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
108
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
108
01:26Aneurysm III: Interprofessional Care
82
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
82
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
153
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
153
01:25Aortic Regurgitation III: Medical Management
119
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
119
01:30Acute Coronary Syndrome III: Diagnostic Studies
67
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
67